FDA Inspection 1246916 — Lek D.D.
The FDA completed an inspection of Lek D.D. on Jul 26, 2024 in Ljubljana. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ljubljana (Slovenia)
Additional Details
Bioanalytical BA/BE